Wyden Statement on Aduhelm Price Change
Senate Finance Committee Chair Ron Wyden, D-Ore., today issued a statement after Biogen, the maker of an Alzheimer's drug called Aduhelm, announced a price decrease for the drug: "…
Senate Finance Committee Chair Ron Wyden, D-Ore., today issued a statement after Biogen, the maker of an Alzheimer's drug called Aduhelm, announced a price decrease for the drug: "…